Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism
by Hu K, Xu Y, Fan J, Liu H, Di C, Xu F, Wu L, Ding K, Zhang T, Wang L, Ai H, Xie L, Wang G and Liang Y (2024). Front. Pharmacol. 15:1387409. doi: 10.3389/fphar.2024.1387409
Due to a production error, an incorrect number was provided for “the National Natural Science Foundation of China”. The correct number is 82274194.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: glutathione, acute hepatic encephalopathy, oxidative stress, endoplasmic reticulum stress, iNOS/ATF4/Ddit3
Citation: Frontiers Production Office (2024) Erratum: Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism. Front. Pharmacol. 15:1534991. doi: 10.3389/fphar.2024.1534991
Received: 26 November 2024; Accepted: 26 November 2024;
Published: 09 December 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn